Drug Type Synthetic peptide |
Synonyms- |
Action- |
Mechanism GD2 stimulants(Disialoganglioside GD2 stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Infectious Diseases | Discovery | - | 10 Nov 2023 | |
Infectious Diseases | Discovery | - | 10 Nov 2023 | |
Neoplasms | Discovery | - | 10 Nov 2023 | |
Neoplasms | Discovery | - | 10 Nov 2023 | |
Pain | Discovery | - | 10 Nov 2023 | |
Pain | Discovery | - | 10 Nov 2023 |